Merck Registers HIV Drug With Medicines Patent Pool, Allowing For Production Of Low-Cost Pediatric Formulations

Associated Press: Merck grants free license for pediatric HIV drug
“Drugmaker Merck & Co. has granted a free license allowing one of its HIV medicines to be made and sold inexpensively for use in young children in poor countries hard hit by the AIDS virus…” (Johnson, 2/24).

Reuters: Merck places children’s HIV drug in shared non-profit patent pool
“…The non-profit Medicines Patent Pool (MPP), which aims to persuade leading drug companies to share rights to their products with generic manufacturers, said on Tuesday the deal for Merck’s raltegravir would add to the treatment arsenal…” (Hirschler, 2/24).